Trials / Withdrawn
WithdrawnNCT01423487
Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea
Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea:a 24-week, Randomized, Placebo-controlled, Double-blind, Fixed-dose Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Central South University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Some previous studies has demonstrated that Metformin can improve the weight gain which caused by antipsychotics. An our study, which will be published, also found that Metformin can improve the amenorrhea for patients with antipsychotics, approximately 60% patients recovery period. So the present study was designed to investigate the efficacy and safety of Metformin in preventing patients with Risperidone from weight gain and amenorrhea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | 0.5g bid 26 weeks |
| OTHER | Starch tablets | 0.5g bid 26 weeks |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-02-01
- Completion
- 2013-08-01
- First posted
- 2011-08-26
- Last updated
- 2012-08-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01423487. Inclusion in this directory is not an endorsement.